Trials / Conditions / Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR CM)
Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR CM)
4 registered clinical trials studyying Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR CM) — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Active Not Recruiting | The CARDIO-TTRansform Scintigraphy Sub-study NCT06073587 | Ionis Pharmaceuticals, Inc. | — |
| Enrolling By Invitation | An Extension Study to Assess Long-Term Safety of Eplontersen in Adults With Transthyretin-Mediated Amyloid Car NCT05667493 | Ionis Pharmaceuticals, Inc. | Phase 3 |
| Active Not Recruiting | CARDIO-TTRansform Magnetic Resonance Imaging (MRI) Sub-study NCT06073574 | Ionis Pharmaceuticals, Inc. | — |
| Active Not Recruiting | CARDIO-TTRansform: A Study to Evaluate the Efficacy and Safety of Eplontersen (Formerly Known as ION-682884, I NCT04136171 | Ionis Pharmaceuticals, Inc. | Phase 3 |